Tubridge Flow Diverter Study For Intracranial Aneurysms

NCT05646108 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2022-12-12

No results posted yet for this study

Summary

The scope of this trial is the collection and analysis of the important safety outcomes in the real world, related to the use of the Tubridge flow diverter in the treatment of intracranial aneurysms.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Endovascular treatment

Endovascular treatment

Sponsors & Collaborators

  • MicroPort NeuroTech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jianmin Liu, Ph.D · Changhai Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-18
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05646108 on ClinicalTrials.gov